华仁药业
(300110)
| 流通市值：31.43亿 | | | 总市值：31.45亿 |
| 流通股本：11.81亿 | | | 总股本：11.82亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 233,382,288.83 | 212,735,254.78 | 185,489,224.63 | 138,973,139.03 |
| 应收票据及应收账款 | 433,219,959.62 | 466,546,893.06 | 508,451,507.77 | 493,016,522.08 |
| 其中：应收票据 | 10,546,222.11 | 10,601,795.27 | 8,974,741.36 | 8,881,287.2 |
| 应收账款 | 422,673,737.51 | 455,945,097.79 | 499,476,766.41 | 484,135,234.88 |
| 应收款项融资 | 90,626,777.6 | 94,658,489.33 | 77,271,979.17 | 62,190,448.64 |
| 预付款项 | 38,596,066.34 | 38,131,843.75 | 43,675,751.63 | 18,991,170.31 |
| 其他应收款合计 | 21,011,188.03 | 21,101,760.61 | 28,776,649.04 | 20,992,442.82 |
| 存货 | 234,680,289.99 | 239,992,914.64 | 245,724,313 | 241,508,622.4 |
| 其他流动资产 | 16,231,554.76 | 16,362,840.42 | 16,681,558.29 | 18,203,471.8 |
| 流动资产合计 | 1,067,748,125.17 | 1,089,529,996.59 | 1,106,070,983.53 | 993,875,817.08 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 15,984,624 | 15,984,624 | 15,984,624 | 15,984,624 |
| 投资性房地产 | 8,595,528.24 | 8,667,588.78 | 8,739,649.32 | 8,811,709.86 |
| 固定资产 | 934,853,076.52 | 954,088,990.36 | 972,409,744.62 | 992,152,153.89 |
| 在建工程 | 97,691,737.94 | 96,303,040.15 | 96,242,972.15 | 100,025,374.03 |
| 使用权资产 | 1,180,471.97 | 1,259,178.23 | 1,337,884.49 | 1,416,590.75 |
| 无形资产 | 267,602,413.12 | 273,082,513.68 | 278,509,200.88 | 284,049,114.33 |
| 开发支出 | 3,873,090.71 | 3,716,173.4 | 3,450,575.99 | 3,252,524.39 |
| 商誉 | 207,894,530.07 | 207,894,530.07 | 207,894,530.07 | 207,894,530.07 |
| 长期待摊费用 | 3,690,402.03 | 4,622,981.7 | 5,467,733.39 | 6,470,374.49 |
| 递延所得税资产 | 71,091,029.79 | 71,118,090.55 | 70,904,061.46 | 70,989,989.99 |
| 其他非流动资产 | 29,760,688.78 | 23,322,227.07 | 20,653,742.52 | 17,079,321.29 |
| 非流动资产合计 | 1,642,217,593.17 | 1,660,059,937.99 | 1,681,594,718.89 | 1,708,126,307.09 |
| 资产总计 | 2,709,965,718.34 | 2,749,589,934.58 | 2,787,665,702.42 | 2,702,002,124.17 |
| 流动负债: | | | | |
| 短期借款 | 384,844,056.43 | 429,903,909.25 | 437,197,928.51 | 330,423,835.62 |
| 应付票据及应付账款 | 166,545,126.8 | 180,858,767.99 | 179,741,472.05 | 199,904,877.91 |
| 应付账款 | 166,545,126.8 | 180,858,767.99 | 179,741,472.05 | 199,904,877.91 |
| 预收款项 | 1,259,726.67 | 1,690,166.5 | 1,693,181.02 | 1,693,181.02 |
| 合同负债 | 33,599,633.95 | 30,984,920.66 | 29,503,932.81 | 33,706,137.41 |
| 应付职工薪酬 | 14,831,917.61 | 14,288,920.93 | 15,075,540.87 | 15,507,032.69 |
| 应交税费 | 18,939,873.79 | 14,906,182.45 | 30,626,148.83 | 21,205,743.8 |
| 其他应付款合计 | 238,179,462.08 | 235,462,184.54 | 261,505,886.32 | 235,229,941.9 |
| 一年内到期的非流动负债 | 394,579,101.19 | 448,599,851.19 | 389,289,101.19 | 633,864,417.75 |
| 其他流动负债 | 4,531,716.88 | 4,357,761.33 | 4,055,624.8 | 2,996,947.35 |
| 流动负债合计 | 1,257,310,615.4 | 1,361,052,664.84 | 1,348,688,816.4 | 1,474,532,115.45 |
| 非流动负债: | | | | |
| 长期借款 | 469,550,660 | 400,741,375 | 464,134,925 | 270,219,200 |
| 租赁负债 | 960,534.68 | 1,107,435.51 | 1,097,490.18 | 785,973.29 |
| 长期应付款 | - | - | 0 | - |
| 长期应付职工薪酬 | - | - | 0 | - |
| 递延收益 | 8,697,003.1 | 8,385,844.53 | 8,286,985.29 | 7,049,148.55 |
| 递延所得税负债 | 38,070,487.65 | 38,832,097.98 | 39,593,708.29 | 40,355,318.62 |
| 非流动负债合计 | 517,278,685.43 | 449,066,753.02 | 513,113,108.76 | 318,409,640.46 |
| 负债合计 | 1,774,589,300.83 | 1,810,119,417.86 | 1,861,801,925.16 | 1,792,941,755.91 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,182,212,982 | 1,182,212,982 | 1,182,212,982 | 1,182,212,982 |
| 资本公积 | 528,044,115.47 | 528,044,115.47 | 528,044,115.47 | 528,044,115.47 |
| 盈余公积 | 90,528,384.95 | 90,528,384.95 | 90,528,384.95 | 90,528,384.95 |
| 未分配利润 | -935,984,515.13 | -934,356,798.97 | -946,940,609.31 | -962,899,211.04 |
| 归属于母公司股东权益合计 | 864,800,967.29 | 866,428,683.45 | 853,844,873.11 | 837,886,271.38 |
| 少数股东权益 | 70,575,450.22 | 73,041,833.27 | 72,018,904.15 | 71,174,096.88 |
| 股东权益合计 | 935,376,417.51 | 939,470,516.72 | 925,863,777.26 | 909,060,368.26 |
| 负债和股东权益合计 | 2,709,965,718.34 | 2,749,589,934.58 | 2,787,665,702.42 | 2,702,002,124.17 |
| 公告日期 | 2026-10-28 | 2026-08-27 | 2026-04-24 | 2026-04-24 |
| 审计意见(境内) | | | | 标准无保留意见 |